Cambridge Investment Research Advisors
AGN

Cambridge Investment Research Advisors’s Allergan plc AGN Stock Holding History

Cambridge Investment Research Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-12,776
Closed -$2.26M – 2545
2020
Q1 		$2.26M Sell
12,776
-4,835
-27% -$910K 0.02% 617
2019
Q4 		$3.37M Sell
17,611
-354
-2% -$63.9K 0.03% 601
2019
Q3 		$3.02M Buy
17,965
+1,607
+10% +$262K 0.03% 602
2019
Q2 		$2.74M Sell
16,358
-4,201
-20% -$582K 0.03% 599
2019
Q1 		$3.01M Sell
20,559
-70
-0.3% -$10.1K 0.03% 564
2018
Q4 		$2.76M Sell
20,629
-755
-4% -$124K 0.03% 526
2018
Q3 		$4.07M Buy
21,384
+32
+0.1% +$5.88K 0.04% 432
2018
Q2 		$3.56M Sell
21,352
-203
-0.9% -$32.6K 0.04% 439
2018
Q1 		$3.63M Buy
21,555
+2,418
+13% +$406K 0.04% 410
2017
Q4 		$3.13M Buy
19,137
+3,321
+21% +$596K 0.04% 436
2017
Q3 		$3.24M Buy
15,816
+2,852
+22% +$663K 0.04% 387
2017
Q2 		$3.15M Buy
12,964
+185
+1% +$43.5K 0.05% 371
2017
Q1 		$3.05M Sell
12,779
-1,331
-9% -$310K 0.05% 331
2016
Q4 		$2.96M Sell
14,110
-3,080
-18% -$638K 0.06% 316
2016
Q3 		$3.96M Sell
17,190
-1,031
-6% -$252K 0.07% 263
2016
Q2 		$4.21M Buy
18,221
+3,374
+23% +$778K 0.09% 209
2016
Q1 		$3.98M Buy
14,847
+3,038
+26% +$870K 0.09% 207
2015
Q4 		$3.69M Sell
11,809
-336
-3% -$100K 0.09% 224
2015
Q3 		$3.3M Buy
+12,145
New +$3.73M 0.09% 213
2014
Q4 		– Sell
-4,122
Closed -$995K – 1518
2014
Q3 		$995K Buy
+4,122
New +$922K 0.03% 526
2013
Q4 		– Sell
-3,420
Closed -$492K – 1292
2013
Q3 		$492K Buy
3,420
+923
+37% +$123K 0.02% 637
2013
Q2 		$315K Buy
+2,497
New +$283K 0.02% 741

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Cambridge Investment Research Advisors's AGN Position: Q2 2020 in Review

Cambridge Investment Research Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 12,776 shares — an estimated $2.26M sold.

Cambridge Investment Research Advisors first reported a position in AGN in Q2 2013 and held it in 22 quarters. The position peaked at $4.21M in Q2 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Cambridge Investment Research Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 12,776 Allergan plc shares in Q2 2020, an estimated $2.26M.
  • Cambridge Investment Research Advisors first reported a position in Allergan plc in Q2 2013 and held it in 22 quarters.
  • Cambridge Investment Research Advisors's Allergan plc position peaked at $4.21M in Q2 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2020, filed 27 Jul 2020.